Hepatitis e virus seropositivity in hemodialysis patients in hatay province, Turkey

Basit Öğe Kaydı
dc.authorscopusid23092280800
dc.authorscopusid18036804900
dc.authorscopusid24825191700
dc.authorscopusid12796585800
dc.authorscopusid24921345900
dc.authorscopusid24921110500
dc.contributor.authorUçar, Edip
dc.contributor.authorÇetin, Meryem
dc.contributor.authorKuvandik, Ceren
dc.contributor.authorHelvaci, Mehmet Rami
dc.contributor.authorGüllü, Murat
dc.contributor.authorHüzmeli, Can
dc.date.accessioned2024-09-19T15:48:33Z
dc.date.available2024-09-19T15:48:33Z
dc.date.issued2009
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractHepatitis E virus (HEV) which is mainly transmitted through faecal-oral route, can also be transmitted via parenteral and vertical route. Recent studies suggest zoonotic nature of the virus. The last studies done in Turkey indicate increasing frequency of HEV infection. This study was conducted to determine the rate of anti-HEV seropositivity among patients with terminal stage renal failure undergoing he-modialysis. A total of 92 patients (54 male, 38 female; age range: 22-71 years, mean age: 55 ± 11 years) who had undergone hemodialysis for a mean period of 66 ± 18 months, were included to the study. HEV antibodies were analyzed using anti-HEV IgG enzyme immunoassay (ELISA, Dia. Pro Diagnostic Bioprobes, Italy). In order to study the relationship of anti-HEV positivity between hepatitis C virus and hepatitis B virus infections, anti-HCV antibody and HBsAg were also considered. Mean age, duration of hemodialysis, platelet, serum albumin, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, blood transfusion history were the other evaluated parameters. Anti-HEV IgC positivity was detected in 19 (20.6%) patients, while 7 (7.6%) had anti-HCV positivity and 4 (4.3%) had HBsAg positivity. No statistically significant relation was determined between anti-HEV IgC positive and negative patients in terms of hemodialysis duration, blood transfusion, other laboratory findings and anti-HCV and HBsAg positivity (p > 0.05). While the anti-HEV seropositivity rate (20.6%) determined in this study was higher than the rates determined in the same group of patients in the western part of the country (10-16%), the rate was similar to the rates reported from the southeastern part (23%) of Turkey. It can be concluded that screening of patients before or during hemodialysis in terms of anti-HEV antibodies, seems to be of crucial importance in order to establish necessary precautions to prevent parenteral and/or nosocomial transmission of HEV.en_US
dc.identifier.endpage302en_US
dc.identifier.issn0374-9096
dc.identifier.issue2en_US
dc.identifier.pmid19621616en_US
dc.identifier.scopus2-s2.0-67649519973en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage299en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12483/15149
dc.identifier.volume43en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isotren_US
dc.relation.ispartofMikrobiyoloji Bultenien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHemodialysisen_US
dc.subjectHepatitis E virusen_US
dc.subjectSeropositivityen_US
dc.subjectTurkeyen_US
dc.titleHepatitis e virus seropositivity in hemodialysis patients in hatay province, Turkeyen_US
dc.title.alternativeHatay'da hemodi?yali?z tedavi?si? alan hastalarda hepati?t e vi?rus seropozi?ti?fli??i?en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu